orbofiban has been researched along with Diseases, Peripheral Vascular in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bentley, J; Blatt, A; Braunwald, E; Cannon, CP; Caspi, A; Charlesworth, A; Cotter, G; Kaluski, E; Krakover, R; Lewis, B; Marmor, A; McCabe, CH; Michowitz, Y; Milo, O; Reisin, L; Vered, Z; Zimlichman, R | 1 |
1 trial(s) available for orbofiban and Diseases, Peripheral Vascular
| Article | Year |
|---|---|
Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? Results from the Orbofiban in Patients with Unstable Coronary Syndromes-Thrombolysi
Topics: Aged; Alanine; Aspirin; Cerebrovascular Disorders; Coronary Disease; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Multivariate Analysis; Peripheral Vascular Diseases; Platelet Aggregation Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Prospective Studies; Pyrrolidines; Regression Analysis; Risk Factors; Treatment Outcome | 2003 |